The following Webcast was recorded at The Premier Business Leadership Series in London on May 6, 2009.
Globalization, economic turmoil and the spread of technology are bringing rapid and disruptive change to new and old businesses alike. How will you adapt?
Our CEO panel, which includes Jim Goodnight, CEO of SAS, and David Brennan, CEO of AstraZeneca, will share insights on how organizations in key and emerging economies compete and prosper; how organizations can become more strategic and proactive; and how leaders can create an employee environment that spontaneously generates creative capital in the form of innovative products, processes and services.
Jim Davis, Chief Marketing Officer at SAS moderate the executive panel discussion.
SAS, in association with BetterManagement, is pleased to present The Premier Business Leadership Series, an exclusive, invitation-only event focusing on the business topics facing global leaders today. This series unites thought leaders and senior executives from around the world for new and inspired performance outcomes.
About Jim Goodnight, CEO, SAS; David Brennan, CEO, AstraZeneca; Jim Davis, CMO, SAS
Jim Goodnight
CEO
SAS
Since he co-founded SAS in 1976, Jim Goodnight has served as the company’s Chief Executive Officer. A worldwide leader in enterprise intelligence solutions and services, SAS has more than 10,000 employees in 53 countries. In 2007, the company’s revenue was $2.1 billion, its 32nd consecutive year of growth and profitability. In 2004, Harvard Business School named him as one of the "20th Century’s Great American Business Leaders," citing his impact on "the way people have lived, worked and interacted in the 20th century." Goodnight has a PhD in statistics and speaks internationally on leadership, education and innovation.
David Brennan
Chief Executive Officer
AstraZeneca
David Brennan was appointed CEO of AstraZeneca in 2006. From 2001 until his appointment to CEO, Brennan was President and CEO of AstraZeneca LP, the company’s North American subsidiary. He was appointed Executive Board Director of AstraZeneca in 2005, with responsibility for the US, the company's largest market, as well as all North American operations.
Brennan began his career in 1975 at Merck, where he rose from sales representative to general manager of Chibret International, a French subsidiary of Merck. He joined AstraMerck in 1992 and helped build its multibillion-dollar business in the US.
Brennan is an Executive Director of AstraZeneca PLC, a member of the executive board of the Pharmaceutical Research and Manufacturers of America (PhRMA) and a member of the executive board of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Jim Davis
Senior Vice President and Chief Marketing Officer
SAS
As Senior Vice President and Chief Marketing Officer, Jim Davis provides worldwide marketing direction for SAS® solutions and services. He is responsible for managing product direction, professional services, education, advertising and communications.
A respected thought leader, Davis co-authored the book Information Revolution: Using the Information Evolution Model to Grow Your Business.
Since joining SAS in 1994, Davis has pioneered many key initiatives, including global projects that incorporate customer feedback in the development process. Today, he continues to refine the model for continuous collaboration and innovation among engineers, marketers and customers, enabling SAS to meet the global demand for enterprise intelligence.
